keyboard_arrow_up

Mice Model Market expected to reach USD 1.75 Billion in 2023

According to a new market report published by Transparency Market Research “Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, the global mice model market was valued at USD 1.01 billion in 2013 and is anticipated to expand at a CAGR of 6.4% from 2015 to 2023 to reach USD 1.75 billion by 2023.


Get the Full Report at:

http://www.transparencymarketresearch.com/mice-model-market.html


Mice have been one of the most important research tools for basic and applied research in biomedical sciences and continues to grow at a rapid rate. Besides providing precise correlation with human condition, the major advantage of mice models is the prospect of exploring precise gene-specific functions and various molecular events in a living organism. Combining mice models with advanced imaging technologies provide unique opportunities to understand the etiology and pathophysiology of human diseases. Furthermore, mice have been widely used in biomedical research to discover human diseases and to evaluate new drug candidates. Mouse research has led to major advances in treating a number of diseases and conditions. For example, experiments on mice models resulted in efficacious treatments for acute promyelocytic leukemia, or APL, which was largely terminal.


An expanding collection of gene technology, together with sequencing of the mice genome and biological conservation, place the mouse at the leading position as a model to decode mechanisms underlying human disease progression. More than any other genetically tractable research animal, mice offer a close view of human biology in terms of resemblance with the pathophysiology, cellular structure, and organization. With 99% of their genes shared with humans, new possibilities were opened in genetic testing, drug discovery, and other basic research. Furthermore, the conservation of genetic association within the mice and human genomes with respect to the encoded genes and their alignment along chromosomes has been a great advantage in identification of potentially conforming homologous mutations and disease genes.


The global mice model market has been segmented on the basis of model type, specialty, services, and geography. Based on model type, the market has been segmented into hybrid/congenic, transplantation mouse, transgenic, knockout, carcinogen-induced and spontaneous mouse, outbred, inbred, and conditioned/surgically modified. Inbred was the largest segment of the global mice model market in 2014 due to advantages such as cost effectiveness and data reproducibility. Moreover, the hybrid/congenic segment is expected to expand at the highest CAGR during the forecast period from 2015 to 2023 due to increasing applications in immunology, oncology, and cardiovascular studies. Based on specialty, the market has been segmented into immunology, central nervous system, oncology, cardiovascular, diabetes, and metabolism & regulation. Metabolic & regulatory diseases was the largest specialty segment of the market in terms of revenue in 2014. The diabetes mice models specialty segment is likely to expand at the highest growth rate due to rising prevalence of the disease across the globe, particularly in developed countries. Some of the prominent services offered to end-users include breeding and rederivation, cryopreservation and cryorecovery, quarantine services, genetic testing, model in-licensing, in vivo and in vitro pharmacology services, genetically engineered model services, and other services such as surgical and line rescue. The major factor influencing the growth of the services market is the growing importance of customized models in applied research as well as in the development and production of vital biomolecules.


Get Free Sample Report Copy at :

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085


Key players operating in the global mice model market include Charles River Laboratories, Crescendo Biologics Limited, Deltagen, Inc., GenOway S.A., Harlan Laboratories, Inc., ImmunoGenes AG, Taconic Biosciences, Inc., Lexicon Pharmaceuticals, SAGE Labs, The Jackson Laboratory, and TransGenic, Inc.


About TMR


Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.


Contact TMR


Mr.Sudip S

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com